Maxim Group Significantly Raises Achillion's PT, Shares Soar +15%
June 16, 2014 at 09:34 AM EDT
Maxim Group analyst Jason Kolbert raised the price target on Buy rated Achillion Pharmaceuticals (NASDAQ: ACHN) from $6.00 to $22.00. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.